Sheldon Litwin

University of Utah

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (5)

Ryan J. Tedford

Medical University of South Carolina

UNITED STATES

Riccardo M. Inciardi

Michael Zile

Medical University of South Carolina

UNITED STATES

Sanjiv Shah

Northwestern University

UNITED STATES

Seth Baum

Chief Medical Officer

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sheldon Litwin

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (5)

Ryan J. Tedford

Riccardo M. Inciardi

Michael Zile

Sanjiv Shah

Seth Baum

Make your next move.

Sheldon Litwin

Research Interests

Explore related searches

Contact this professor

Articles (20)

GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction?

Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity

Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs HFpEF

Epicardial adipose tissue, functional status and invasive hemodynamics in heart failure with preserved ejection fraction.

Quantifying Mitral Annular Calcification With Echocardiography: Comparison to Calcium Score With Computed Tomography

Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials

Executive Summary from the 2023 Charleston HFpEF Conference

Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP‐HF II trial

A Multimodality Imaging Approach to Defining Risk in Patients With Acute Pulmonary Embolism

Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction

Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction

Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction

The Intriguing Links Among Patent Foramen Ovale, Patent Foramen Ovale Closure, and the Risk for Heart Failure

Computed Tomography in Patients With Left Ventricular Dysfunction

Update on Atrial Shunt Therapy for Treatment of Heart Failure

Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction

Pharmacologic Weight Loss for Heart Failure With Preserved Ejection Fraction

Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure

Collaborators (5)

Ryan J. Tedford

Riccardo M. Inciardi

Michael Zile

Sanjiv Shah

Seth Baum

Make your next move.